Patents by Inventor James L. Babb

James L. Babb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220151275
    Abstract: A dietary supplement for improving gastrointestinal functionality includes: an edible supplement comprising at least 10 mg/mL of alcohol soluble components of an animal broth. A method for preparing a dietary supplement for improving gastrointestinal functionality includes the steps of: transforming an animal broth into an active agent by adding a transforming vehicle to the animal broth, wherein the transforming vehicle is an alcohol; isolating the active agent by removing precipitates; removing the transforming vehicle from the active agent; and forming the dietary supplement, wherein the dietary supplement includes the active agent.
    Type: Application
    Filed: January 28, 2022
    Publication date: May 19, 2022
    Inventors: James L. Babb, James J. Koziarz, Raymond J. Laudano
  • Publication number: 20180199608
    Abstract: A dietary supplement for improving gastrointestinal functionality includes: an edible supplement comprising at least 10 mg/mL of alcohol soluble components of an animal broth. A method for preparing a dietary supplement for improving gastrointestinal functionality includes the steps of: transforming an animal broth into an active agent by adding a transforming vehicle to the animal broth, wherein the transforming vehicle is an alcohol; isolating the active agent by removing precipitates; removing the transforming vehicle from the active agent; and forming the dietary supplement, wherein the dietary supplement includes the active agent.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 19, 2018
    Inventors: James L. Babb, James J. Koziarz, Raymond J. Laudano
  • Patent number: 4717652
    Abstract: Peritoneal inflammation or infection can be detected in a patient by assaying a peritoneal lavage sample from the patient for lysosomal enzymes. This is done by combining the lavage sample with a leukocyte lysing agent and a chromogenic or fluorogenic enzyme substrate specific for lysosomal enzymes. The lysosomal enzymes can then be measured, and the inflammation of infection detected, by measuring the color or fluorescence developed in the sample by action of the enzymes on the substrate.
    Type: Grant
    Filed: October 22, 1986
    Date of Patent: January 5, 1988
    Assignee: Abbott Laboratories
    Inventors: James L. Babb, Timothy G. Bloomster, Jon A. Rudbach
  • Patent number: 4654298
    Abstract: Peritoneal inflammation or infection can be detected in a patient by assaying a peritoneal lavage sample from the patient for lysosomal enzymes. This is done by combining the lavage sample with a leukocyte lysing agent and a chromogenic or fluorogenic enzyme substrate specific for lysosomal enzymes. The lysosomal enzymes can then be measured, and the inflammation or infection detected, by measuring the color or fluorescence developed in the sample by action of the enzymes on the substrate.
    Type: Grant
    Filed: October 5, 1984
    Date of Patent: March 31, 1987
    Assignee: Abbott Laboratories
    Inventors: James L. Babb, Timothy G. Bloomster, Jon A. Rudbach